Abstract
BackgroundPoor adherence to medication regimens is a major cause of relapse during systemic lupus erythematosus (SLE). Hydroxychloroquine (HCQ), the main therapy of SLE, has a long half-life. Thus, undetectable blood...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have